Literature DB >> 18992980

Kidney involvement in multicentric castleman disease.

Sumeet Suneja1, Mala Chidambaram, Andrew M Herzenberg, Joanne M Bargman.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18992980     DOI： 10.1053/j.ajkd.2008.08.026

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  4 in total

Review 1.  Renal complications of Castleman's disease: report of two cases and analysis of 75 cases.

Authors:  Xiang-Gui Yuan; Wen Hu; Fei-Fei Chen; Bin-Feng Huang; Xiao-Ying Zhao
Journal:  Clin Exp Nephrol       Date:  2011-08-06       Impact factor: 2.801

2.  Efficacy of tocilizumab, a humanized neutralizing antibody against interleukin-6 receptor, in progressive renal injury associated with Castleman's disease.

Authors:  Akito Maeshima; Masao Nakasatomi; Daizo Henmi; Shin Yamashita; Yoriaki Kaneko; Takashi Kuroiwa; Keiju Hiromura; Yoshihisa Nojima
Journal:  CEN Case Rep       Date:  2012-03-17

Review 3.  Multicentric Castleman's disease: a challenging diagnosis.

Authors:  Györgyi Műzes; Ferenc Sipos; Judit Csomor; Lídia Sréter
Journal:  Pathol Oncol Res       Date:  2013-03-21       Impact factor: 3.201

4.  The efficacy and safety of anti-interleukin-6 receptor monoclonal blockade in a renal transplant patient with Castleman disease: early post-transplant outcome.

Authors:  Masatoshi Matsunami; Yoshifumi Ubara; Keiichi Sumida; Yoichi Oshima; Masahiko Oguro; Kazuya Kinoshita; Kiho Tanaka; Yuki Nakamura; Keiichi Kinowaki; Kenichi Ohashi; Takeshi Fujii; Takuro Igawa; Yasuharu Sato; Yasuo Ishii
Journal:  BMC Nephrol       Date:  2018-10-11       Impact factor: 2.388
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.